Randomized study comparing the efficacy of Hericium versus essential oils against Helicobacter pylori (HP) infection;Étude randomisée comparant l'efficacité d'Hericium erinaceus versus huiles essentielles sur Helicobacter pylori (HP)

Phytotherapie

Volumn 12, Issue 1, 2014, Pages 3-5

  Donatini, B ^a  

^a Gastro entérologue hépatologue DES cancérologue DESC immunologue DEA DESC   (France)

Author keywords

Crossover study; Essential oils; Helicobacter; Hericium

Indexed keywords

ANTIINFECTIVE AGENT; ESSENTIAL OIL; HERBACEOUS AGENT;

ABSENCE OF SIDE EFFECTS; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; HELICOBACTER INFECTION; HERICIUM; HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84896392774     PISSN: 16248597     EISSN: 17652847     Source Type: Journal    
DOI: 10.1007/s10298-014-0831-5     Document Type: Article

References (23)

1. Bergonzelli GE, Donnicola D, Porta N, Corthésy-Theulaz IE (2003) Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrob Agents Chemother 10: 3240-6 (Pubitemid 37229584)
2. Dobbs RJ, Dobbs SM, Weller C, et al. (2008) Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 5: 309-22
3. Esmaeili D, Mobarez AM, Tohidpour A (2012) Anti-Helicobacter pylori activities of shoya powder and essential oils of thymus vulgaris and eucalyptus globulus. Open Microbiol J 6: 65-9
4. Gisbert JP (2005) The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 9: 2083-99
5. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts [archive]. Gut 49: 347-53 (Pubitemid 32802568)
6. Imai H, Osawa K, Yasuda H, et al. (2001) Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios 106: 31-9 (Pubitemid 33689350)
7. Inoue I, Mukoubayashi C, Yoshimura N, et al. (2011) Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 11: 2704-11
8. Jung J, Lee JH, Bae KH, Jeong CS (2011) Anti-gastric actions of eugenol and cinnamic acid isolated from Cinnamomi Ramulus. Yakugaku Zasshi 7: 1103-10
9. Kamangar F, Sheikhattari P, Mohebtash M (2011) Helicobacter pylori and its effects on human health and disease. Arch Iran Med 3: 192-9
10. Kodama M, Murakami K, Okimoto T, et al. (2012) Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 4: 394-403
11. Kountouras J, Boziki M, Gavalas E, et al. (2010) Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 3: 199-204
12. Lin J, Huang WW (2009) A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine. World J Gastroenterol 37: 4715-9
13. Lin Y, Ueda J, Kikuchi S, et al. (2011) Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 39: 4421-8
14. Malfertheiner P, Megraud F, O'Morain CA, et al. (2012) Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut 5: 646-64
15. Nir Y, Potasman I, Stermer E, et al. (2000) Controlled trial of the effect of cinnamon extract on Helicobacter pylori. Helicobacter 2: 94-7 (Pubitemid 34948014)
16. O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. (2005) Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 47: 7499-507 (Pubitemid 43126033)
17. Qian J, Ye F, Zhang J, et al. (2012) Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. Helicobacter 6: 478-85
18. Risch HA (2012) Pancreatic cancer: Helicobacter pylori colonization, N-Nitrosamine exposures, and ABO blood group. Mol Carcinog 1: 109-18
19. Sachs G, Scott DR, Wen Y (2011) Gastric Infection by Helicobacter pylori. Curr Gastroenterol Rep 6: 540-6
20. Sugizaki K, Sakata Y, Arai T, et al. (2012) A multicenter prospective observational study of triple therapy with rabeprazole, amoxicillin and metronidazole for Helicobacter pylori in Japan. Intern Med 22: 3103-8
21. Tabak M, Armon R, Potasman I, Neeman I (1996) In vitro inhibition of Helicobacter pylori by extracts of thyme. J Appl Bacteriol 6: 667-72 (Pubitemid 26184737)
22. Tabak M, Armon R, Neeman I (1999) Cinnamon extracts' inhibitory effect on Helicobacter pylori. J Ethnopharmacol 3: 269-77 (Pubitemid 29469736)
23. Xu CP, Liu WW, Liu FX, et al. (1985) A double-blind study of effectiveness of hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report. Chin Med J (Engl) 6: 455-6